Skip to content

Use of Stratafix Symmetric™ to Prevent Incisional Hernia in Gastrointestinal and Abdominal Surgery

A Randomized Controlled Trial Evaluating the Use of Stratafix Symmetric™ to Prevent Incisional Hernia in Gastrointestinal and Abdominal Surgery

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06063577
Acronym
STRATA-G
Enrollment
100
Registered
2023-10-02
Start date
2023-12-01
Completion date
2026-12-31
Last updated
2024-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C.Surgical Procedure; Disruption of Wound, Suture

Brief summary

Comparing the use of Stratafix Symmetric™ sutures to standard laparotomy closure sutures.

Detailed description

Determine whether the use of Stratafix Symmetric™ sutures reduces the development of Ventral Incisional Hernia (VIH) in patients undergoing complex GI surgery compared to standard laparotomy closure. Determine the safety of Stratafix Symmetric™ sutures compared to standard laparotomy closure sutures and the impact on quality of life and level of pain.

Interventions

Stratafix symmetric suture

DEVICEStandard of care suture

Standard of care suture

Sponsors

Ethicon, Inc.
CollaboratorINDUSTRY
West Michigan Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Patients will be blinded after the assignment.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Participant is a male or female 18 years of age or older. 2. Participant is a current patient at West Michigan Cancer Center. 3. Participant is undergoing liver, pancreas or biliary or gastrointestinal surgery of a combination of the above, or other major oncological surgery. 4. Participant is willing and able to provide written informed consent before surgery.

Exclusion criteria

1. Participant has hemodynamic instability at the conclusion of the surgery. (These subjects will be deemed disqualified). 2. Participant has history of previous VIH. 3. Participant has a mental condition rendering the subject incapable of understanding the nature, scope and consequences of the study.

Design outcomes

Primary

MeasureTime frameDescription
Number of participants who develop ventral incisional herniaFrom enrollment to end of study participation at 12 monthsInfection, seroma, surgical site infection, evisceration, mesh rejection, systemic complications

Secondary

MeasureTime frameDescription
Safety of stratafix sutures compared to standard of care wound closureFrom enrollment to end of study participation at 12 monthsAssessing adverse events related to the suture
Change in quality of lifeMonth 1, Month 3, Month 6, Month 12Carolinas Comfort Scale (CCS) questionnaire (a validated, disease-specific, quality of life (QOL) questionnaire developed for patients undergoing hernia repair)
Post operative painFrom enrollment to end of study participation at 12 monthsVisual analog score

Countries

United States

Contacts

Primary ContactWendi Mitchell
research@wmcc.org269-373-7443

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026